Avanos maintains $665M-$685M revenue target amid HA divestiture and tariff impact
Source: SeekingAlpha
2025-08-05 13:27:14 ET
More on Avanos Medical
- Avanos Medical, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
- Avanos Medical Non-GAAP EPS of $0.17 beats by $0.02, revenue of $175M beats by $9.5M
- Seeking Alpha’s Quant Rating on Avanos Medical
- Historical earnings data for Avanos Medical
Read the full article on Seeking Alpha
For further details see:
Avanos maintains $665M–$685M revenue target amid HA divestiture and tariff impact
Avanos Medical Inc.
NASDAQ: AVNS
AVNS Trading
3.63% G/L:
$13.86 Last:
124,280 Volume:
$13.67 Open:
AVNS Latest News
March 02, 2026 05:28:00 pm
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
February 26, 2026 07:00:00 am
Avanos Medical, Inc. to Nominate James Cunniff and William Burke to Board of Directors
February 24, 2026 07:00:00 am
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
AVNS Stock Data
$683,750,500
45,954,718
0.18%
112
N/A
Medical Equipment & Supplies
Healthcare
US
Alpharetta
